Suchergebnisse - %22Combined Modality Therapy%22

PubPharm (2)

1

Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis : a multicenter cohort study

enthalten in: Breast cancer (Tokyo, Japan) | 2023

von Kawamoto, T. | Shikama, N. | Imano, N. | +14

2

Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic Breast Cancer

enthalten in: Clinical breast cancer | 2020

von Ratosa, I. | Orazem, M. | Scoccimarro, E. | +9

1
[1]